1
|
Volz L, Liu P, Tessonnier T, Cong X, Durante M, Mairani A, Gu W, Abdollahi A, Ding X, Graeff C, Li T, Mein S. HyperSHArc: Single-Isocenter Stereotactic Radiosurgery of Multiple Brain Metastases Using Proton, Helium, and Carbon Ion Arc Therapy. Adv Radiat Oncol 2025; 10:101763. [PMID: 40264854 PMCID: PMC12013133 DOI: 10.1016/j.adro.2025.101763] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/17/2024] [Accepted: 03/09/2025] [Indexed: 04/24/2025] Open
Abstract
Purpose This work presents a proof-of-concept study of HyperSHArc, spot-scanning hadron arc (SHArc) therapy for single-isocenter stereotactic radiosurgery of multiple brain metastases (MBMs). HyperSHArc plans using proton, helium, and carbon ions were compared with state-of-the-art volumetric modulated photon arc therapy. Methods and Materials Treatment design and optimization procedures were devised using commercial and in-house treatment planning systems. Planning and delivery methods considered dedicated energy, spot, and multiarc selection strategies. Proton, helium, and carbon HyperSHArc plans were generated for patients with MBM exhibiting 3 to 11 intracranial lesions with gross tumor volumes (GTVs) between 0.03 and 19.8 cc, at prescribed doses between 19 and 21Gy in a single-fraction. Planning target volumes (PTVs) considered a 1-mm isotropic margin around the GTV, and robust optimization with 2.5%/1 mm criteria for range and position uncertainty was applied. Photon hyper-arc volumetric modulated arc therapy (HA-VMAT) plans were optimized for the PTVs using the HyperArc® single-isocenter stereotactic radiosurgery platform (Varian, Palo Alto, CA, USA). Results HyperSHArc plans were comparable between particle species, achieving highly conformal target doses and satisfying clinical coverage criteria. Particle arc plans reduced V2Gy and V4Gy in the healthy brain compared with HA-VMAT, while intermediate doses (V8Gy-V16Gy) were similar or reduced depending on the number of lesions. Particularly for the case with 11 targets, a considerable reduction in V12Gy was observed that could be relevant for reducing the risk of treatment-induced radionecrosis. HyperSHArc using carbon ions boosted dose-averaged linear energy transfer inside the target relevant to overcoming radioresistance factors (>100 keV/μm). Conclusions We present the first particle arc therapy strategies for MBM. Results demonstrate that with HyperSHArc, dose conformity comparable or superior to HA-VMAT is achievable while reducing the low-dose bath and increasing mean dose-averaged linear energy transfer in the GTV. Our findings suggest that HyperSHArc using light and heavy ions could be an effective and efficient means of treating MBM. Further development of HyperSHArc optimization and delivery is justified.
Collapse
Affiliation(s)
- Lennart Volz
- Biophysics, GSI Helmholtz Centre for Heavy Ion Research GmbH, Darmstadt, Germany
| | - Peilin Liu
- Department of Radiation Oncology, Corewell Health, Royal Oak, Michigan
| | - Thomas Tessonnier
- Heidelberg Ion Beam Therapy Center (HIT), Heidelberg, Germany
- Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany
- Heidelberg Institute of Radiation Oncology (HIRO), German Cancer Research Center (DKFZ), Heidelberg, Germany
- German Cancer Consortium (DKTK), Heidelberg, Germany
| | - Xiaoda Cong
- Department of Radiation Oncology, Corewell Health, Royal Oak, Michigan
| | - Marco Durante
- Biophysics, GSI Helmholtz Centre for Heavy Ion Research GmbH, Darmstadt, Germany
- Department is Institute of Condensed Matter Physics, Institute of Condensed Matter Physics, TU Darmstadt, Darmstadt, Germany
| | - Andrea Mairani
- Heidelberg Ion Beam Therapy Center (HIT), Heidelberg, Germany
- Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany
- Heidelberg Institute of Radiation Oncology (HIRO), German Cancer Research Center (DKFZ), Heidelberg, Germany
- German Cancer Consortium (DKTK), Heidelberg, Germany
- Division of Molecular and Translational Radiation Oncology, National Center for Tumor Diseases (NCT), Heidelberg University Hospital, Heidelberg, Germany
- National Centre of Oncological Hadrontherapy (CNAO), Medical Physics, Pavia, Italy
| | - Wenbo Gu
- Department of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania
| | - Amir Abdollahi
- Heidelberg Ion Beam Therapy Center (HIT), Heidelberg, Germany
- Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany
- Heidelberg Institute of Radiation Oncology (HIRO), German Cancer Research Center (DKFZ), Heidelberg, Germany
- German Cancer Consortium (DKTK), Heidelberg, Germany
- Division of Molecular and Translational Radiation Oncology, National Center for Tumor Diseases (NCT), Heidelberg University Hospital, Heidelberg, Germany
| | - Xuanfeng Ding
- Department of Radiation Oncology, Corewell Health, Royal Oak, Michigan
| | - Christian Graeff
- Biophysics, GSI Helmholtz Centre for Heavy Ion Research GmbH, Darmstadt, Germany
- Department of electrical engineering and information technology, TU Darmstadt, Darmstadt, Germany
| | - Taoran Li
- Department of Radiation Oncology, University of Pennsylvania, Philadelphia, Pennsylvania
| | - Stewart Mein
- Heidelberg Ion Beam Therapy Center (HIT), Heidelberg, Germany
- Heidelberg Institute of Radiation Oncology (HIRO), German Cancer Research Center (DKFZ), Heidelberg, Germany
- German Cancer Consortium (DKTK), Heidelberg, Germany
- Department of Accelerator and Medical Physics, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology (QST), Chiba, Japan
| |
Collapse
|
2
|
Steinsberger T, Nakas A, Vai A, Molinelli S, Donetti M, Pullia M, Martire MC, Galeone C, Ciocca M, Pella A, Vitolo V, Barcellini A, Orlandi E, Imparato S, Volz L, Baroni G, Paganelli C, Durante M, Graeff C. Evaluation of motion mitigation strategies for carbon ion therapy of abdominal tumors based on non-periodic imaging data. Phys Med Biol 2025; 70:065002. [PMID: 39978068 DOI: 10.1088/1361-6560/adb89b] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/19/2024] [Accepted: 02/20/2025] [Indexed: 02/22/2025]
Abstract
Objective.To identify suitable combination strategies for treatment planning and beam delivery in scanned carbon ion therapy of moving tumors.Approach. Carbon ion treatment plans for five abdominal tumors were optimized on four-dimensional (4D) computed tomography (CT) data using the following approaches. 4DITV across all phases and within a gating window, single phase uniform dose, and an innovative 4D tracking internal target volume (ITV) strategy. Delivered single-fraction doses were calculated on time-resolved virtual CT images reconstructed from 2D cine-magnetic resonance imaging series, using a deformable image registration pipeline. Treatment plans were combined with various beam delivery techniques: three-dimensional (no motion mitigation), rescanning, gating, beam tracking, and multi-phase 4D delivery with and without residual tracking (MP4D and MP4DRT) to form in total 11 treatment modalities. Single fraction doses were accumulated to simulate a fractionated treatment.Main results. Breath-sampled treatments using the MP4D and MP4DRT delivery techniques were the only to achieveD95> 95% for hypofractionated treatments, with little dependence on the number of fractions. A combination of MP4DRT with the new 4D tracking ITV approach resulting in conformal dose distributions and demonstrated the greatest robustness against irregular motion and anatomical changes.Significance. This study demonstrates, that real-time adaptive beam delivery strategies can deliver conformal doses within single fractions, thereby enabling hypofractionated treatment schemes that are not feasible with conventional strategies.
Collapse
Affiliation(s)
- Timo Steinsberger
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, Biophysics, Darmstadt, Germany
| | - Anestis Nakas
- Politecnico di Milano, Department of Electronics, Information and Bioengineering, Milano, Italy
| | - Alessandro Vai
- Department of Medical Physics, CNAO National Center for Oncological Hadrontherapy, Pavia, Italy
| | - Silvia Molinelli
- Department of Medical Physics, CNAO National Center for Oncological Hadrontherapy, Pavia, Italy
| | - Marco Donetti
- Research Department, CNAO National Center for Oncological Hadrontherapy, Pavia, Italy
| | - Marco Pullia
- Research Department, CNAO National Center for Oncological Hadrontherapy, Pavia, Italy
| | - Maria Chiara Martire
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, Biophysics, Darmstadt, Germany
- Department of Electrical Engineering and Information Technology, Technical University of Darmstadt, Darmstadt, Germany
| | - Cosimo Galeone
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, Biophysics, Darmstadt, Germany
- Department of Electrical Engineering and Information Technology, Technical University of Darmstadt, Darmstadt, Germany
| | - Mario Ciocca
- Department of Medical Physics, CNAO National Center for Oncological Hadrontherapy, Pavia, Italy
| | - Andrea Pella
- CNAO National Center for Oncological Hadrontherapy, Bioengineering Unit, Pavia, Italy
| | - Viviana Vitolo
- Clinical Department, CNAO National Center for Oncological Hadrontherapy, Pavia, Italy
| | - Amelia Barcellini
- Clinical Department, CNAO National Center for Oncological Hadrontherapy, Pavia, Italy
- Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy
| | - Ester Orlandi
- Clinical Department, CNAO National Center for Oncological Hadrontherapy, Pavia, Italy
| | - Sara Imparato
- Clinical Department, CNAO National Center for Oncological Hadrontherapy, Pavia, Italy
| | - Lennart Volz
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, Biophysics, Darmstadt, Germany
| | - Guido Baroni
- Politecnico di Milano, Department of Electronics, Information and Bioengineering, Milano, Italy
- CNAO National Center for Oncological Hadrontherapy, Bioengineering Unit, Pavia, Italy
| | - Chiara Paganelli
- Politecnico di Milano, Department of Electronics, Information and Bioengineering, Milano, Italy
| | - Marco Durante
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, Biophysics, Darmstadt, Germany
- Technical University of Darmstadt, Institute of Condensed Matter Physics, Darmstadt, Germany
| | - Christian Graeff
- GSI Helmholtzzentrum für Schwerionenforschung GmbH, Biophysics, Darmstadt, Germany
- Department of Electrical Engineering and Information Technology, Technical University of Darmstadt, Darmstadt, Germany
| |
Collapse
|
3
|
Reidel CA, Pierobon E, Horst F, Gesson L, Paz A, Graeff C, Steinsberger T, Zink K, Witt M, Senger Y, Finck C, Vanstalle M, La Tessa C, Durante M, Weber U, Schuy C. Feasibility study of 4D-online monitoring of density gradients induced by lung cancer treatment using carbon ions. Front Oncol 2025; 15:1502960. [PMID: 40078180 PMCID: PMC11896988 DOI: 10.3389/fonc.2025.1502960] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/27/2024] [Accepted: 02/03/2025] [Indexed: 03/14/2025] Open
Abstract
Tumor motion is a major challenge for scanned ion-beam therapy. In the case of lung tumors, strong under- and overdosage can be induced due to the high density gradients between the tumor- and bone tissues compared to lung tissues. This work proposes a non-invasive concept for 4D monitoring of high density gradients in carbon ion beam therapy, by detecting charged fragments. The method implements CMOS particle trackers that are used to reconstruct the fragment vertices, which define the emission points of nuclear interactions between the primary carbon ions and the patient tissues. A 3D treatment plan was optimized to deliver 2 Gy to a static spherical target volume. The goodness of the method was assessed by comparing reconstructed vertices measured in two static cases to the ones in a non-compensated moving case with an amplitude of 20 mm. The measurements, performed at the Marburg Ion-Beam Therapy Center (MIT), showed promising results to assess the conformity of the delivered dose. In particular to measure overshoots induced by high density gradients due to motion with 83.0 ± 1.5% and 92.0 ± 1.5% reliability based on the ground truth provided by the time-resolved motor position and depending on the considered volume and the iso-energy layers.
Collapse
Affiliation(s)
- Claire-Anne Reidel
- Biophysics Department, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
| | - Enrico Pierobon
- UNITN-TIFPA, University of Trento, Trento Institute for Fundamental Physics and Applications, Trento, Italy
| | - Felix Horst
- Biophysics Department, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
| | - Lévana Gesson
- Biophysics Department, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
- Université de Strasbourg, CNRS, IPHC UMR 7871, Strasbourg, France
| | - Athena Paz
- Biophysics Department, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
| | - Christian Graeff
- Biophysics Department, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
- Institute of Electrical Engineering and Information Technology, Technische Universität Darmstadt, Darmstadt, Germany
| | - Timo Steinsberger
- Biophysics Department, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
| | - Klemens Zink
- Institute of Medical Physics and Radiation Protection (IMPS), University of Applied Sciences, Giessen, Germany
- Marburg Ion-Beam Therapy Center MIT, Marburg, Germany
| | - Matthias Witt
- Institute of Medical Physics and Radiation Protection (IMPS), University of Applied Sciences, Giessen, Germany
- Marburg Ion-Beam Therapy Center MIT, Marburg, Germany
| | | | - Christian Finck
- Université de Strasbourg, CNRS, IPHC UMR 7871, Strasbourg, France
| | - Marie Vanstalle
- Université de Strasbourg, CNRS, IPHC UMR 7871, Strasbourg, France
| | - Chiara La Tessa
- UNITN-TIFPA, University of Trento, Trento Institute for Fundamental Physics and Applications, Trento, Italy
- Radiation Oncology Department, University of Miami, Miami, FL, United States
| | - Marco Durante
- Biophysics Department, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
- Institute of Condensed Matter Physics, Technische Universität Darmstadt, Darmstadt, Germany
- Department of Physics “Ettore Pancini”, University Federico II, Naples, Italy
| | - Uli Weber
- Biophysics Department, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
- Institute of Medical Physics and Radiation Protection (IMPS), University of Applied Sciences, Giessen, Germany
| | - Christoph Schuy
- Biophysics Department, GSI Helmholtzzentrum für Schwerionenforschung GmbH, Darmstadt, Germany
| |
Collapse
|
4
|
Fullarton R, Simard M, Volz L, Toltz A, Chung S, Schuy C, Robertson DG, Royle G, Beddar S, Baker C, Graeff C, Collins‐Fekete C. Imaging lung tumor motion using integrated-mode proton radiography-A phantom study towards tumor tracking in proton radiotherapy. Med Phys 2025; 52:1146-1158. [PMID: 39530503 PMCID: PMC11788258 DOI: 10.1002/mp.17508] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/20/2024] [Revised: 10/10/2024] [Accepted: 10/19/2024] [Indexed: 11/16/2024] Open
Abstract
BACKGROUND Motion of lung tumors during radiotherapy leads to decreased accuracy of the delivered dose distribution. This is especially true for proton radiotherapy due to the finite range of the proton beam. Methods for mitigating motion rely on knowing the position of the tumor during treatment. PURPOSE Proton radiography uses the treatment beam, at an energy high enough to traverse the patient, to produce a radiograph. This work shows the first results of using an integrated-mode proton radiography system to track the position of moving objects in an experimental phantom study; demonstrating the potential of using this method for measuring tumor motion. METHODS Proton radiographs of an anthropomorphic lung phantom, with a motor-driven tumor insert, were acquired approximately every 1 s, using tumor inserts of 10, 20, and 30 mm undergoing a known periodic motion. The proton radiography system used a monolithic scintillator block and digital cameras to capture the residual range of each pencil beam passing through the phantom. These ranges were then used to produce a water equivalent thickness map of the phantom. The centroid of the tumor insert in the radiographs was used to determine its position. This measured position was then compared to the known motion of the phantom to determine the accuracy. RESULTS Submillimeter accuracy on the measurement of the tumor insert was achieved when using a 30 mm tumor insert with a period of 24 s and was found to be improved for decreasing motion amplitudes with a mean absolute error (MAE) of 1.0, 0.9, and 0.7 mm for 20, 15, and 10 mm respectively. Using smaller tumor inserts reduced the accuracy with a MAE of 1.8 and 1.9 mm for a 20 and 10 mm insert respectively undergoing a periodic motion with an amplitude of 20 mm and a period of 24 s. Using a shorter period resulted in significant motion artifacts reducing the accuracy to a MAE of 2.2 mm for a 12 s period and 3.1 mm for a 6 s period for the 30 mm insert with an amplitude of 20 mm. CONCLUSIONS This work demonstrates that the position of a lung tumor insert in a realistic anthropomorphic phantom can be measured with high accuracy using proton radiographs. Results show that the accuracy of the position measurement is the highest for slower tumor motions due to a reduction in motion artifacts. This indicates that the primary obstacle to accurate measurement is the speed of the radiograph acquisition. Although the slower tumor motions used in this study are not clinically realistic, this work demonstrates the potential for using proton radiography for measuring tumor motion with an increased scanning speed that results in a decreased acquisition time.
Collapse
Affiliation(s)
- Ryan Fullarton
- Department of Medical Physics and Biomedical EngineeringUniversity College LondonLondonUK
| | - Mikaël Simard
- Department of Medical Physics and Biomedical EngineeringUniversity College LondonLondonUK
| | - Lennart Volz
- BiophysicsGSI Helmholtz Centre for Heavy Ion Research GmbHDarmstadtGermany
| | - Allison Toltz
- Department of Radiotherapy PhysicsUniversity College London HospitalNHS Foundation TrustLondonUK
| | - Savanna Chung
- Department of Radiotherapy PhysicsUniversity College London HospitalNHS Foundation TrustLondonUK
| | - Christoph Schuy
- BiophysicsGSI Helmholtz Centre for Heavy Ion Research GmbHDarmstadtGermany
| | - Daniel G. Robertson
- Division of Medical PhysicsDepartment of Radiation OncologyMayo Clinic ArizonaPhoenixArizonaUSA
| | - Gary Royle
- Department of Medical Physics and Biomedical EngineeringUniversity College LondonLondonUK
| | - Sam Beddar
- Department of Radiation PhysicsThe University of Texas MD Anderson Cancer CenterHoustonTexasUSA
| | - Colin Baker
- Department of Radiotherapy PhysicsUniversity College London HospitalNHS Foundation TrustLondonUK
| | - Christian Graeff
- BiophysicsGSI Helmholtz Centre for Heavy Ion Research GmbHDarmstadtGermany
| | | |
Collapse
|
5
|
Mein S, Wuyckens S, Li X, Both S, Carabe A, Vera MC, Engwall E, Francesco F, Graeff C, Gu W, Hong L, Inaniwa T, Janssens G, de Jong B, Li T, Liang X, Liu G, Lomax A, Mackie T, Mairani A, Mazal A, Nesteruk KP, Paganetti H, Pérez Moreno JM, Schreuder N, Soukup M, Tanaka S, Tessonnier T, Volz L, Zhao L, Ding X. Particle arc therapy: Status and potential. Radiother Oncol 2024; 199:110434. [PMID: 39009306 DOI: 10.1016/j.radonc.2024.110434] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/09/2023] [Revised: 06/23/2024] [Accepted: 07/10/2024] [Indexed: 07/17/2024]
Abstract
There is a rising interest in developing and utilizing arc delivery techniques with charged particle beams, e.g., proton, carbon or other ions, for clinical implementation. In this work, perspectives from the European Society for Radiotherapy and Oncology (ESTRO) 2022 physics workshop on particle arc therapy are reported. This outlook provides an outline and prospective vision for the path forward to clinically deliverable proton, carbon, and other ion arc treatments. Through the collaboration among industry, academic, and clinical research and development, the scientific landscape and outlook for particle arc therapy are presented here to help our community understand the physics, radiobiology, and clinical principles. The work is presented in three main sections: (i) treatment planning, (ii) treatment delivery, and (iii) clinical outlook.
Collapse
Affiliation(s)
- Stewart Mein
- Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA, USA; Heidelberg Ion-Beam Therapy Center (HIT), Heidelberg, Germany; Division of Molecular and Translational Radiation Oncology, National Center for Tumor Diseases (NCT), Heidelberg University Hospital, Heidelberg, Germany; Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
| | - Sophie Wuyckens
- UCLouvain, Molecular Imaging, Radiotherapy and Oncology (MIRO), Brussels, Belgium
| | - Xiaoqiang Li
- Department of Radiation Oncology, Corewell Health, William Beaumont University Hospital, Proton Therapy Center, Royal Oak, MI, USA
| | - Stefan Both
- Department of Radiation Oncology, University Medical Center Groningen, Groningen, The Netherlands
| | | | - Macarena Chocan Vera
- UCLouvain, Molecular Imaging, Radiotherapy and Oncology (MIRO), Brussels, Belgium
| | | | | | - Christian Graeff
- GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany; Technische Universität Darmstadt, Institut für Physik Kondensierter Materie, Darmstadt, Germany
| | - Wenbo Gu
- Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA, USA
| | - Liu Hong
- Ion Beam Applications SA, Louvain-la-Neuve, Belgium
| | - Taku Inaniwa
- Department of Accelerator and Medical Physics, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology, Chiba, Japan; Department of Medical Physics and Engineering, Graduate School of Medicine, Division of Health Sciences, Osaka University, Osaka, Japan
| | | | - Bas de Jong
- Department of Radiation Oncology, University Medical Center Groningen, Groningen, The Netherlands
| | - Taoran Li
- Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA, USA
| | - Xiaoying Liang
- Department of Radiation Oncology, Mayo Clinic Jacksonville, Jacksonville, FL, USA
| | - Gang Liu
- Department of Radiation Oncology, Corewell Health, William Beaumont University Hospital, Proton Therapy Center, Royal Oak, MI, USA; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
| | - Antony Lomax
- Centre for Proton Therapy, Paul Scherrer Institute, Villigen, Switzerland; ETH, Department of Physics, Zürich, Switzerland
| | - Thomas Mackie
- Department of Human Oncology, University of Wisconsin School of Medicine, Madison, WI, USA
| | - Andrea Mairani
- Heidelberg Ion-Beam Therapy Center (HIT), Heidelberg, Germany; National Centre of Oncological Hadrontherapy (CNAO), Medical Physics, Pavia, Italy
| | | | - Konrad P Nesteruk
- Department of Radiation Oncology, Massachusetts General Hospital, Boston, USA; Harvard Medical School, Boston, USA
| | - Harald Paganetti
- Department of Radiation Oncology, Massachusetts General Hospital, Boston, USA; Harvard Medical School, Boston, USA
| | | | | | | | - Sodai Tanaka
- Department of Accelerator and Medical Physics, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology, Chiba, Japan
| | | | - Lennart Volz
- GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany; Technische Universität Darmstadt, Institut für Physik Kondensierter Materie, Darmstadt, Germany
| | - Lewei Zhao
- Department of Radiation Oncology, Stanford University, Stanford, CA, USA
| | - Xuanfeng Ding
- Department of Radiation Oncology, Corewell Health, William Beaumont University Hospital, Proton Therapy Center, Royal Oak, MI, USA.
| |
Collapse
|
6
|
Galeone C, Steinsberger T, Donetti M, Martire MC, Milian FM, Sacchi R, Vignati A, Volz L, Durante M, Giordanengo S, Graeff C. Real-time delivered dose assessment in carbon ion therapy of moving targets. Phys Med Biol 2024; 69:205001. [PMID: 39299266 DOI: 10.1088/1361-6560/ad7d59] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/24/2024] [Accepted: 09/19/2024] [Indexed: 09/22/2024]
Abstract
Objective. Real-time adaptive particle therapy is being investigated as a means to maximize the treatment delivery accuracy. To react to dosimetric errors, a system for fast and reliable verification of the agreement between planned and delivered doses is essential. This study presents a clinically feasible, real-time 4D-dose reconstruction system, synchronized with the treatment delivery and motion of the patient, which can provide the necessary feedback on the quality of the delivery.Approach. A GPU-based analytical dose engine capable of millisecond dose calculation for carbon ion therapy has been developed and interfaced with the next generation of the dose delivery system (DDS) in use at Centro Nazionale di Adroterapia Oncologica (CNAO). The system receives the spot parameters and the motion information of the patient during the treatment and performs the reconstruction of the planned and delivered 4D-doses. After each iso-energy layer, the results are displayed on a graphical user interface by the end of the spill pause of the synchrotron, permitting verification against the reference dose. The framework has been verified experimentally at CNAO for a lung cancer case based on a virtual phantom 4DCT. The patient's motion was mimicked by a moving Ionization Chamber (IC) 2D-array.Mainresults. For the investigated static and 4D-optimized treatment delivery cases, real-time dose reconstruction was achieved with an average pencil beam dose calculation speed up to more than one order of magnitude smaller than the spot delivery. The reconstructed doses have been benchmarked against offline log-file based dose reconstruction with the TRiP98 treatment planning system, as well as QA measurements with the IC 2D-array, where an average gamma-index passing rate (3%/3 mm) of 99.8% and 98.3%, respectively, were achieved.Significance. This work provides the first real-time 4D-dose reconstruction engine for carbon ion therapy. The framework integration with the CNAO DDS paves the way for a swift transition to the clinics.
Collapse
Affiliation(s)
- C Galeone
- Biophysics, GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
- Department of Electrical Engineering and Information Technology, TU Darmstadt, Darmstadt, Germany
- Dipartimento di Fisica, Università degli Studi di Torino, Torino, Italy
| | - T Steinsberger
- Biophysics, GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
| | - M Donetti
- Centro Nazionale di Adroterapia Oncologica (CNAO), Pavia, Italy
| | - M C Martire
- Biophysics, GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
- Department of Electrical Engineering and Information Technology, TU Darmstadt, Darmstadt, Germany
| | - F M Milian
- Istituto Nazionale di Fisica Nucleare, Torino, Italy
- Universidade Estadual de Santa Cruz, Ilheus, Brazil
| | - R Sacchi
- Dipartimento di Fisica, Università degli Studi di Torino, Torino, Italy
- Istituto Nazionale di Fisica Nucleare, Torino, Italy
| | - A Vignati
- Dipartimento di Fisica, Università degli Studi di Torino, Torino, Italy
- Istituto Nazionale di Fisica Nucleare, Torino, Italy
| | - L Volz
- Biophysics, GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
| | - M Durante
- Biophysics, GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
- Institute for Condensed Matter Physics, TU Darmstadt, Darmstadt, Germany
- Dipartimento di Fisica, Università Federico II, Napoli, Italy
| | - S Giordanengo
- Istituto Nazionale di Fisica Nucleare, Torino, Italy
| | - C Graeff
- Biophysics, GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
- Department of Electrical Engineering and Information Technology, TU Darmstadt, Darmstadt, Germany
| |
Collapse
|
7
|
Quarz A, Volz L, Antink CH, Durante M, Graeff C. Deep learning-based voxel sampling for particle therapy treatment planning. Phys Med Biol 2024; 69:155014. [PMID: 38917844 DOI: 10.1088/1361-6560/ad5bba] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/10/2024] [Accepted: 06/25/2024] [Indexed: 06/27/2024]
Abstract
Objective.Scanned particle therapy often requires complex treatment plans, robust optimization, as well as treatment adaptation. Plan optimization is especially complicated for heavy ions due to the variable relative biological effectiveness. We present a novel deep-learning model to select a subset of voxels in the planning process thus reducing the planning problem size for improved computational efficiency.Approach.Using only a subset of the voxels in target and organs at risk (OARs) we produced high-quality treatment plans, but heuristic selection strategies require manual input. We designed a deep-learning model based onP-Net to obtain an optimal voxel sampling without relying on patient-specific user input. A cohort of 70 head and neck patients that received carbon ion therapy was used for model training (50), validation (10) and testing (10). For training, a total of 12 500 carbon ion plans were optimized, using a highly efficient artificial intelligence (AI) infrastructure implemented into a research treatment planning platform. A custom loss function increased sampling density in underdosed regions, while aiming to reduce the total number of voxels.Main results.On the test dataset, the number of voxels in the optimization could be reduced by 84.8% (median) at <1% median loss in plan quality. When the model was trained to reduce sampling in the target only while keeping all voxels in OARs, a median reduction up to 71.6% was achieved, with 0.5% loss in the plan quality. The optimization time was reduced by a factor of 7.5 for the total AI selection model and a factor of 3.7 for the model with only target selection.Significance.The novel deep-learning voxel sampling technique achieves a significant reduction in computational time with a negligible loss in the plan quality. The reduction in optimization time can be especially useful for future real-time adaptation strategies.
Collapse
Affiliation(s)
- A Quarz
- Biophysics Department, GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
- Department of Electrical Engineering and Information Technology, Technische Universität Darmstadt, Darmstadt, Germany
| | - L Volz
- Biophysics Department, GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
| | - C Hoog Antink
- Department of Electrical Engineering and Information Technology, Technische Universität Darmstadt, Darmstadt, Germany
| | - M Durante
- Biophysics Department, GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
- Department of Condensed Matter Physics, Technische Universität Darmstadt, Darmstadt, Germany
- Department of Physics 'Ettore Pancini', University Federico II, Naples, Italy
| | - C Graeff
- Biophysics Department, GSI Helmholtzzentrum für Schwerionenforschung, Darmstadt, Germany
- Department of Electrical Engineering and Information Technology, Technische Universität Darmstadt, Darmstadt, Germany
| |
Collapse
|
8
|
Simard M, Robertson DG, Fullarton R, Royle G, Beddar S, Collins-Fekete CA. Integrated-mode proton radiography with 2D lateral projections. Phys Med Biol 2024; 69:054001. [PMID: 38241716 DOI: 10.1088/1361-6560/ad209d] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/27/2023] [Accepted: 01/19/2024] [Indexed: 01/21/2024]
Abstract
Integrated-mode proton radiography leading to water equivalent thickness (WET) maps is an avenue of interest for motion management, patient positioning, andin vivorange verification. Radiographs can be obtained using a pencil beam scanning setup with a large 3D monolithic scintillator coupled with optical cameras. Established reconstruction methods either (1) involve a camera at the distal end of the scintillator, or (2) use a lateral view camera as a range telescope. Both approaches lead to limited image quality. The purpose of this work is to propose a third, novel reconstruction framework that exploits the 2D information provided by two lateral view cameras, to improve image quality achievable using lateral views. The three methods are first compared in a simulated Geant4 Monte Carlo framework using an extended cardiac torso (XCAT) phantom and a slanted edge. The proposed method with 2D lateral views is also compared with the range telescope approach using experimental data acquired with a plastic volumetric scintillator. Scanned phantoms include a Las Vegas (contrast), 9 tissue-substitute inserts (WET accuracy), and a paediatric head phantom. Resolution increases from 0.24 (distal) to 0.33 lp mm-1(proposed method) on the simulated slanted edge phantom, and the mean absolute error on WET maps of the XCAT phantom is reduced from 3.4 to 2.7 mm with the same methods. Experimental data from the proposed 2D lateral views indicate a 36% increase in contrast relative to the range telescope method. High WET accuracy is obtained, with a mean absolute error of 0.4 mm over 9 inserts. Results are presented for various pencil beam spacing ranging from 2 to 6 mm. This work illustrates that high quality proton radiographs can be obtained with clinical beam settings and the proposed reconstruction framework with 2D lateral views, with potential applications in adaptive proton therapy.
Collapse
Affiliation(s)
- Mikaël Simard
- Department of Medical Physics and Biomedical Engineering, University College London, London, United Kingdom
| | - Daniel G Robertson
- Division of Medical Physics, Department of Radiation Oncology, Mayo Clinic Arizona, 5881 E Mayo Blvd, Phoenix, AZ, United States of America
| | - Ryan Fullarton
- Department of Medical Physics and Biomedical Engineering, University College London, London, United Kingdom
| | - Gary Royle
- Department of Medical Physics and Biomedical Engineering, University College London, London, United Kingdom
| | - Sam Beddar
- The University of Texas MD Anderson UTHealth Graduate School of Biomedical Sciences, Houston, TX, United States of America
| | | |
Collapse
|